术前血清NGAL预测心脏术后急性肾损伤与死亡率
本研究为对接受冠状动脉旁路移植术成人患者试验的事后分析,1371例有术前血清NGAL数据。结果显示,随术前NGAL三分位升高,术后急性肾损伤发生率及1年心血管和全因死亡率均增加,第三分位(>220 ng/L)者1年心血管和全因死亡风险约增两倍。
要点
- 术前血清NGAL三分位升高与术后急性肾损伤发生率增加相关。
- 术前NGAL第三分位(>220 ng/L)者1年心血管和全因死亡风险约增两倍。
- 术前NGAL或可用于心脏术后风险分层。
核心结论
- 在接受心脏手术的高危成人患者中,术前血清NGAL从第一至第三分位升高,术后急性肾损伤和1年死亡率随之增加。
- 术前NGAL第三分位(>220 ng/L)者1年心血管和全因死亡风险估计约增两倍。
研究设计与样本
- 本研究为对Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patient Undergoing Coronary Artery Bypass Graft Surgery试验的事后分析,纳入接受冠状动脉旁路移植术的成人患者。
- 1612例患者中1371例有术前血清NGAL数据。
- 术后72小时内急性肾损伤采用国际肾脏病改善全球预后分类定义。
主要发现
- 总体1年心血管死亡率为5.2%(71/1371),全因死亡率为7.7%(105/1371)。
- 术前NGAL第一至第三分位术后急性肾损伤发生率分别为30.5%、41.5%和45.9%(p<0.001)。
- 术前NGAL第一至第三分位1年心血管和全因死亡率均增加,线性趋势检验调整后p分别为0.018和0.013。
- 与第一分位相比,第二和第三分位术前NGAL的1年心血管死亡调整HR分别为1.60(95% CI 0.78至3.25)和2.22(95% CI 1.13至4.35)。
- 与第一分位相比,第二和第三分位术前NGAL的1年全因死亡调整HR分别为1.25(95% CI 0.71至2.22)和1.91(95% CI 1.13至3.25)。
关键数值与推荐
- 术前血清NGAL第三分位定义为>220 ng/L。
- 术后急性肾损伤定义为术后72小时内符合国际肾脏病改善全球预后分类。
临床怎么用
- 对于接受冠状动脉旁路移植术的成人患者,可考虑检测术前血清NGAL以辅助识别术后急性肾损伤和1年死亡高风险者。
- 术前NGAL>220 ng/L提示1年心血管和全因死亡风险约增两倍,或需加强围术期管理。
局限性
- 本研究为事后分析,结论需前瞻性验证。
- 仅1371/1612例患者有术前血清NGAL数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to investigate whether preoperative serum neutrophil gelatinase-associated lipocalin (sNGALpre-op) predicted postoperative acute kidney injury (AKI) during hospitalisation and 1-year cardiovascular and all-cause mortality following adult cardiac surgery. METHODS: This study was a post hoc analysis of the Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patient Undergoing Coronary Artery Bypass Graft Surgery trial involving adult patients undergoing coronary artery bypass graft. Postoperative AKI within 72 hours was defined using the International Kidney Disease: Improving Global Outcomes classification. RESULTS: 1371 out of 1612 patients had data on sNGALpre-op. The overall 1-year cardiovascular and all-cause mortality was 5.2% (71/1371) and 7.7% (105/1371), respectively. There was an observed increase in the incidence of AKI from the first to the third tertile of sNGALpre-op (30.5%, 41.5% and 45.9%, respectively, p<0.001). There was also an increase in both cardiovascular and all-cause mortality from the first to the third tertile of sNGALpre-op, linear trend test with adjusted p=0.018 and p=0.013, respectively. The adjusted HRs for those in the second and third tertiles of sNGALpre-op compared with the first tertile were 1.60 (95% CI 0.78 to 3.25) and 2.22 (95% CI 1.13 to 4.35) for cardiovascular mortality, and 1.25 (95% CI 0.71 to 2.22) and 1.91 (95% CI 1.13 to 3.25) for all-cause mortality at 1 year. CONCLUSION: In a cohort of high-risk adult patients undergoing cardiac surgery, there was an increase in postoperative AKI and 1-year mortality from the first to the third tertile of preoperative serum NGAL. Those in the last tertile (>220 ng/L) had an estimated twofold increase risk of cardiovascular and all-cause mortality at 1 year. CLINICAL TRIAL REGISTRATION: NCT101247545; Post-results.
引用
- Bulluck H, Maiti R, Chakraborty B, et al. Neutrophil gelatinase-associated lipocalin prior to cardiac surgery predicts acute kidney injury and mortality. Heart. 2017. PMID: 28794136. doi:10.1136/heartjnl-2017-311760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。